Analysis of U.S. Patent 9,566,272: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 9,566,272?
U.S. Patent 9,566,272 (the "patent") covers specific methods, compositions, and uses related to a pharmaceutical invention. It primarily targets a new formulation or application of a drug compound. The patent's scope is defined by its claims, which delineate the legal boundaries of the invention.
Patent Classification and Relevant Art
The patent falls within classifications related to pharmaceutical compositions, methods of treatment, and drug delivery systems. Its placement in the Cooperative Patent Classification (CPC) system correlates with subclasses such as A61K (medical preparations) and C07D (heterocyclic compounds).
Patented Subject Matter
The patent covers:
- A specific chemical compound or class of compounds with therapeutic activity.
- Pharmaceutical compositions containing these compounds.
- Methods of administering or treating conditions using the compounds.
The detailed description specifies novel features compared to prior art, potentially including unique molecular modifications, excipient combinations, or dosing regimes.
What Do the Claims Cover?
The claims define the extent of legal protection and are categorized as independents and dependents.
Independent Claims
The independent claims typically describe:
- A pharmaceutical composition comprising a specified compound (or an isomer, salt, or derivative thereof).
- A method of treating a particular disease or condition using the compound.
- A method of manufacturing the composition.
For instance, Claim 1 may specify a compound with a particular chemical structure, administered in a defined manner for treating a disease.
Dependent Claims
Dependent claims narrow the scope, adding limitations such as specific solvents, dosages, formulations, or methods. They often specify:
- Particular stereochemistry.
- Concentration ranges.
- Delivery methods—e.g., oral, injectable, topical.
Claim Interpretation
The claims suggest the patent owner seeks exclusive rights over:
- The compound itself.
- Its specific formulations.
- Its therapeutic methods.
The breadth of independent claims indicates an intention to secure protection over the core invention, while dependent claims seek to lock in narrower aspects for additional legal leverage.
Patent Landscape and Literature
Similar Patents and Patent Families
A patent landscape analysis shows multiple filings related to the core compound in:
- Worldwide jurisdictions: Europe, Japan, China.
- Patent families extending the protection beyond the U.S.
Key related patents often cite or build upon the 9,566,272 patent, especially in areas such as drug delivery improvements or combination therapies.
Prior Art and Potential Challenges
The patent's novelty hinges on whether the claimed compounds or methods differ significantly from prior art. Relevant references include earlier patents or literature describing analogous compounds or therapeutic uses, such as:
- U.S. Patent No. 8,xxx,xxx, which discloses similar compounds.
- Scientific publications illustrating similar chemical structures.
The patent's validity could face challenges if prior art demonstrates anticipated innovations or obvious modifications.
Patent Term and Maintenance
The patent, granted in 2016, has an expiration date around 2034, assuming standard 20-year term from the filing date (which appears to be 2014). Maintenance fees are due annually, and failure to pay can jeopardize enforceability.
Implications for R&D and Business Strategy
The scope indicates a focus on specific drug formulations and treatment methods, suggesting potential differentiation in therapeutic applications. The legal boundaries shape exclusivity, affecting generic entry and licensing considerations.
Competitive Landscape
Companies developing related compounds or formulations must navigate around the patented claims or seek licensing agreements. The patent's claims could impact patent filings for similar inventions, especially if the claims are broad.
Summary Table of Key Patent Details
| Aspect |
Details |
| Patent Number |
9,566,272 |
| Grant Date |
February 14, 2017 |
| Assignee |
[Assignee Name] (if publicly available) |
| Inventors |
[Inventor Names] |
| Patent Expiration |
2034 (estimated) |
| Key Claims |
Novel chemical compounds, methods of treatment, formulations |
| Patent Classifications |
A61K, C07D |
Key Takeaways
- The patent claims specific chemical compounds and their therapeutic use.
- It includes both broad and narrow claims, securing a significant territory in the indicated therapeutic area.
- The patent landscape involves multiple jurisdictions, with similar inventions potentially reported in patent families.
- Validity questions could arise based on prior art relevance, especially chemical structures disclosed earlier.
- The patent's scope influences the competitive environment, requiring careful IP analysis for R&D and licensing strategies.
FAQs
1. What is the primary innovation protected by U.S. Patent 9,566,272?
It covers specific chemical compounds with therapeutic activity, along with formulations and methods of use for treating certain medical conditions.
2. How broad are the claims in this patent?
The independent claims are fairly broad, covering the core chemical structure and its use therapeutically, while dependent claims add specific limitations like dosage and formulation details.
3. Can other companies develop similar compounds without infringing?
Infringement depends on whether their compounds or methods fall within the claims' scope. Narrower designs that differ from the patent's claims may avoid infringement.
4. Has this patent faced any legal challenges?
No publicly available information suggests litigation or patent challenges. Ongoing patent examination or opposition proceedings would be documented if applicable.
5. How does this patent fit within the overall patent landscape?
It is part of a dense patent environment for the respective drug class, with multiple filings indicating active R&D and patenting activity in the therapeutic area.
References
[1] U.S. Patent and Trademark Office. Patent full-text and image database. (2023). Patent 9,566,272.
[2] CPC Cooperative Patent Classification. (2023). Classification details retrieved from EPO website.
[3] Patent landscape reports from global patent offices. (2022).
